Gema Biotech S.A.
GEMABIOTECH is a biotechnology company developing high-tech medicines for human health. It is a member of AMEGA Biotech, a biopharmaceutical platform that integrates development and production operations, designing all processes from clone selection to protein purification and finished product formulation. The company offers a complete line of first-generation biogenerics and a wide range of second-generation molecules, focusing on active pharmaceutical ingredients and finished products.
Industries
Nr. of Employees
large (251-1000)
Products
Etanercept
Therapeutic recombinant protein (listed product).
Interferon Alfa-2a
Therapeutic recombinant protein (listed product).
Interferon Alfa-2b
Therapeutic recombinant protein (listed product).
Peg-Interferon Alfa-2b
Therapeutic recombinant protein (PEGylated interferon) (listed product).
Interferon Beta-1a
Therapeutic recombinant protein (listed product).
Interferon Beta-1b
Therapeutic recombinant protein (listed product).
Etanercept
Therapeutic recombinant protein (listed product).
Interferon Alfa-2a
Therapeutic recombinant protein (listed product).
Interferon Alfa-2b
Therapeutic recombinant protein (listed product).
Peg-Interferon Alfa-2b
Therapeutic recombinant protein (PEGylated interferon) (listed product).
Interferon Beta-1a
Therapeutic recombinant protein (listed product).
Interferon Beta-1b
Therapeutic recombinant protein (listed product).
Services
Integrated biologics development and manufacturing services
Platform service that integrates development and production activities, offering workflows from clone selection through purified protein and finished product formulation on-site.
Integrated biologics development and manufacturing services
Platform service that integrates development and production activities, offering workflows from clone selection through purified protein and finished product formulation on-site.
Expertise Areas
- End-to-end biologics development and production
- Biogeneric / biosimilar development
- Cell line and clone development
- Upstream and downstream bioprocessing
Key Technologies
- Cell culture-based protein expression
- Chromatography and downstream purification methods
- Formulation development for biologics
- Bioprocess scale-up and manufacturing